Corcept Therapeutics Incorporated
NASDAQ:CORT
57.79 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 482.375 | 401.858 | 365.978 | 353.874 | 306.486 | 251.247 | 159.201 | 81.321 | 50.286 | 26.551 | 10.357 | 3.307 | 0 | 0 | 0.029 | 0.209 | 0.482 | 0.294 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 6.481 | 5.385 | 5.281 | 5.582 | 5.504 | 5.215 | 3.554 | 2.058 | 1.361 | 0.882 | 0.143 | 0.091 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 475.894 | 396.473 | 360.697 | 348.292 | 300.982 | 246.032 | 155.647 | 79.263 | 48.925 | 25.669 | 10.214 | 3.216 | 0 | 0 | 0.029 | 0.209 | 0.482 | 0.294 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.987 | 0.987 | 0.986 | 0.984 | 0.982 | 0.979 | 0.978 | 0.975 | 0.973 | 0.967 | 0.986 | 0.972 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 184.353 | 130.991 | 113.864 | 114.764 | 89.017 | 75.247 | 40.376 | 23.844 | 15.419 | 18.372 | 20.47 | 14.074 | 21.001 | 18.949 | 14.402 | 14.152 | 7.86 | 20.834 | 17.074 | 11.551 | 8.108 | 13.264 | 5.39 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.331 | 8.488 | 5.877 | 5.746 | 4.867 | 5.042 | 4.084 | 4,494.064 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,489.57 | 0 | 0 | 0 |
| SG&A
| 184.259 | 152.848 | 122.356 | 105.326 | 100.359 | 81.289 | 62.416 | 45.24 | 36.949 | 34.916 | 31.24 | 25.414 | 11.331 | 8.488 | 5.877 | 5.746 | 4.867 | 5.042 | 4.084 | 4.494 | 1.887 | 5.531 | 2.616 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.443 | 6.592 | 4.325 | 4.386 | 4.021 | 4.029 | 3.285 | 3,019.115 | 0 | 0 | 0 |
| Operating Expenses
| 368.612 | 283.839 | 236.22 | 220.09 | 189.376 | 156.536 | 102.792 | 69.084 | 52.368 | 53.288 | 51.71 | 39.488 | 32.332 | 27.437 | 20.279 | 19.898 | 12.727 | 25.876 | 21.158 | 16.045 | 9.995 | 18.795 | 8.006 |
| Operating Income
| 107.282 | 112.634 | 124.477 | 128.202 | 111.606 | 89.496 | 52.855 | 10.179 | -3.443 | -27.619 | -41.496 | -36.272 | -32.332 | -27.437 | -20.25 | -19.689 | -12.245 | -25.582 | -21.158 | -16.045 | -9.995 | -18.795 | -8.006 |
| Operating Income Ratio
| 0.222 | 0.28 | 0.34 | 0.362 | 0.364 | 0.356 | 0.332 | 0.125 | -0.068 | -1.04 | -4.007 | -10.968 | 0 | 0 | -698.276 | -94.206 | -25.405 | -87.014 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 17.275 | 3.557 | 0.529 | 3.4 | 5.07 | 2.657 | -0.049 | -2.039 | -2.965 | -3.764 | -4.515 | -1.776 | -0.025 | -0.025 | -0.017 | -1.316 | -0.016 | -0.01 | -0.052 | -0.068 | 0 | 0 | 0 |
| Income Before Tax
| 124.557 | 116.191 | 125.006 | 131.602 | 116.676 | 92.153 | 52.806 | 8.14 | -6.408 | -31.383 | -46.011 | -38.048 | -32.354 | -25.966 | -20.166 | -20.061 | -11.573 | -24.873 | -20.093 | -15,534.481 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0.258 | 0.289 | 0.342 | 0.372 | 0.381 | 0.367 | 0.332 | 0.1 | -0.127 | -1.182 | -4.443 | -11.505 | 0 | 0 | -695.379 | -95.986 | -24.01 | -84.602 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 18.417 | 14.773 | 12.494 | 25.591 | 22.495 | 16.743 | -76.316 | 0 | 0 | 0 | 0 | 0 | 0.022 | -1.471 | -0.084 | 0.372 | -0.672 | -0.709 | -1.065 | -0.51 | -0.182 | 18.504 | 7.454 |
| Net Income
| 106.14 | 101.418 | 112.512 | 106.011 | 94.181 | 75.41 | 129.122 | 8.14 | -6.408 | -31.383 | -46.011 | -38.048 | -32.354 | -25.966 | -20.166 | -20.061 | -11.573 | -24.873 | -20.093 | -15.534 | -9.812 | -18.504 | -7.454 |
| Net Income Ratio
| 0.22 | 0.252 | 0.307 | 0.3 | 0.307 | 0.3 | 0.811 | 0.1 | -0.127 | -1.182 | -4.443 | -11.505 | 0 | 0 | -695.379 | -95.986 | -24.01 | -84.602 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 1.02 | 0.95 | 0.97 | 0.92 | 0.82 | 0.6 | 1.14 | 0.07 | -0.06 | -0.31 | -0.46 | -0.41 | -0.39 | -0.38 | -0.38 | -0.43 | -0.34 | -1.09 | -0.89 | -0.84 | -1.13 | -2.75 | -1.39 |
| EPS Diluted
| 0.94 | 0.87 | 0.89 | 0.85 | 0.77 | 0.6 | 1.04 | 0.07 | -0.06 | -0.31 | -0.46 | -0.41 | -0.39 | -0.38 | -0.38 | -0.43 | -0.34 | -1.09 | -0.89 | -0.84 | -1.13 | -2.75 | -1.39 |
| EBITDA
| 109.644 | 112.634 | 124.477 | 128.202 | 111.606 | 89.496 | 52.855 | 10.266 | -3.288 | -27.478 | -41.422 | -36.245 | -32.304 | -27.406 | -20.223 | -18.361 | -12.216 | -25.558 | -20.402 | -14.367 | -9.972 | -18.795 | -8.006 |
| EBITDA Ratio
| 0.227 | 0.28 | 0.34 | 0.362 | 0.364 | 0.356 | 0.332 | 0.126 | -0.065 | -1.035 | -3.999 | -10.96 | 0 | 0 | -697.345 | -87.852 | -25.344 | -86.932 | 0 | 0 | 0 | 0 | 0 |